Silk Road Medical Stock Shares Outstanding
| SILK Stock | USD 18.90 1.10 6.18% |
Silk Road Medical fundamentals help investors to digest information that contributes to Silk Road's financial success or failures. It also enables traders to predict the movement of Silk Stock. The fundamental analysis module provides a way to measure Silk Road's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Silk Road stock.
The value of Common Stock Shares Outstanding is expected to slide to about 34.2 M. Silk | Shares Outstanding |
Silk Road Medical Company Shares Outstanding Analysis
Silk Road's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Silk Road Shares Outstanding | 39.17 M |
Most of Silk Road's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Silk Road Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Silk Shares Outstanding Driver Correlations
Understanding the fundamental principles of building solid financial models for Silk Road is extremely important. It helps to project a fair market value of Silk Stock properly, considering its historical fundamentals such as Shares Outstanding. Since Silk Road's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Silk Road's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Silk Road's interrelated accounts and indicators.
Click cells to compare fundamentals
Silk Shares Outstanding Historical Pattern
Today, most investors in Silk Road Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Silk Road's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Silk Road shares outstanding as a starting point in their analysis.
Silk Road Shares Outstanding |
| Timeline |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Silk Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, Silk Road Medical has 39.17 M of shares currently outstending. This is 78.3% lower than that of the Health Care Equipment & Supplies sector and 77.61% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 93.15% higher than that of the company.
Silk Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Silk Road's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Silk Road could also be used in its relative valuation, which is a method of valuing Silk Road by comparing valuation metrics of similar companies.Silk Road is currently under evaluation in shares outstanding category among related companies.
Silk Road Current Valuation Drivers
We derive many important indicators used in calculating different scores of Silk Road from analyzing Silk Road's financial statements. These drivers represent accounts that assess Silk Road's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Silk Road's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 927.0M | 2.1B | 1.5B | 1.9B | 476.1M | 452.3M | |
| Enterprise Value | 932.7M | 2.1B | 1.4B | 1.9B | 540.6M | 1.0B |
Silk Fundamentals
| Return On Equity | -0.35 | ||||
| Return On Asset | -0.14 | ||||
| Profit Margin | (0.31) % | ||||
| Operating Margin | (0.30) % | ||||
| Current Valuation | 600.47 M | ||||
| Shares Outstanding | 39.17 M | ||||
| Shares Owned By Insiders | 5.93 % | ||||
| Shares Owned By Institutions | 94.07 % | ||||
| Number Of Shares Shorted | 4.14 M | ||||
| Price To Book | 4.71 X | ||||
| Price To Sales | 4.03 X | ||||
| Revenue | 177.13 M | ||||
| Gross Profit | 100.76 M | ||||
| EBITDA | (55.48 M) | ||||
| Net Income | (55.74 M) | ||||
| Cash And Equivalents | 108.87 M | ||||
| Cash Per Share | 3.09 X | ||||
| Total Debt | 84.63 M | ||||
| Debt To Equity | 1.37 % | ||||
| Current Ratio | 6.92 X | ||||
| Book Value Per Share | 3.86 X | ||||
| Cash Flow From Operations | (32.01 M) | ||||
| Short Ratio | 7.50 X | ||||
| Earnings Per Share | (1.44) X | ||||
| Price To Earnings To Growth | (0.26) X | ||||
| Target Price | 20.17 | ||||
| Number Of Employees | 474 | ||||
| Beta | 1.48 | ||||
| Market Capitalization | 697.31 M | ||||
| Total Asset | 265.31 M | ||||
| Retained Earnings | (399.45 M) | ||||
| Working Capital | 210.55 M | ||||
| Net Asset | 265.31 M |
About Silk Road Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Silk Road Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Silk Road using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Silk Road Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Silk Road in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Silk Road's short interest history, or implied volatility extrapolated from Silk Road options trading.
Currently Active Assets on Macroaxis
When determining whether Silk Road Medical is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Silk Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Silk Road Medical Stock. Highlighted below are key reports to facilitate an investment decision about Silk Road Medical Stock:Check out Silk Road Piotroski F Score and Silk Road Altman Z Score analysis. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for Silk Stock analysis
When running Silk Road's price analysis, check to measure Silk Road's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Silk Road is operating at the current time. Most of Silk Road's value examination focuses on studying past and present price action to predict the probability of Silk Road's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Silk Road's price. Additionally, you may evaluate how the addition of Silk Road to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
Is Silk Road's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Silk Road. If investors know Silk will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Silk Road listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.44) | Revenue Per Share 4.565 | Quarterly Revenue Growth 0.18 | Return On Assets (0.14) | Return On Equity (0.35) |
The market value of Silk Road Medical is measured differently than its book value, which is the value of Silk that is recorded on the company's balance sheet. Investors also form their own opinion of Silk Road's value that differs from its market value or its book value, called intrinsic value, which is Silk Road's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Silk Road's market value can be influenced by many factors that don't directly affect Silk Road's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Silk Road's value and its price as these two are different measures arrived at by different means. Investors typically determine if Silk Road is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Silk Road's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.